{"entity":{"type":"insider","cik":"0001297709","url":"/insider/0001297709","json_url":"/insider/0001297709.json","name":"Novartis Bioventures Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":188,"n_filings":61,"first":"2011-01-21","last":"2020-07-02","span_basis":"filed_date"},"name_variants":[{"name":"Novartis Bioventures Ltd","source":"filing","n_filings":61,"first_seen":"2011-01-21","last_seen":"2020-07-02"}],"transactions":[{"id":3328626,"accession":"0001104659-20-080559","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-080559","line_url":"/filing/0001104659-20-080559#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Akouos, Inc.","issuer_ticker":"AKUS","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":2125000.0,"total_display":"2,125,000.00","total_whole":"2,125,000","shares_owned_after":1181258.0,"shares_owned_after_display":"1,181,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-07-02","scope":"insider"},{"id":2686020,"accession":"0000925421-20-000256","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-20-000256","line_url":"/filing/0000925421-20-000256#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1001312.0,"shares_display":"1,001,312","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":8260824.0,"total_display":"8,260,824.00","total_whole":"8,260,824","shares_owned_after":2467961.0,"shares_owned_after_display":"2,467,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-22","scope":"insider"},{"id":2686016,"accession":"0000925421-20-000256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-20-000256","line_url":"/filing/0000925421-20-000256#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":9.04,"price_display":"9.04","price_state":"stated","total_value":8136.0,"total_display":"8,136.00","total_whole":"8,136","shares_owned_after":3469273.0,"shares_owned_after_display":"3,469,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-18","filed_date":"2020-06-22","scope":"insider"},{"id":2734101,"accession":"0000925421-20-000254","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-20-000254","line_url":"/filing/0000925421-20-000254#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4622.0,"shares_display":"4,622","price_per_share":9.27,"price_display":"9.27","price_state":"stated","total_value":42845.94,"total_display":"42,845.94","total_whole":"42,846","shares_owned_after":3470173.0,"shares_owned_after_display":"3,470,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-17","filed_date":"2020-06-17","scope":"insider"},{"id":2734096,"accession":"0000925421-20-000254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-20-000254","line_url":"/filing/0000925421-20-000254#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8600.0,"shares_display":"8,600","price_per_share":9.3,"price_display":"9.30","price_state":"stated","total_value":79980.0,"total_display":"79,980.00","total_whole":"79,980","shares_owned_after":3474795.0,"shares_owned_after_display":"3,474,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"},{"id":2734092,"accession":"0000925421-20-000254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-20-000254","line_url":"/filing/0000925421-20-000254#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6164.0,"shares_display":"6,164","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":55784.2,"total_display":"55,784.20","total_whole":"55,784","shares_owned_after":3483395.0,"shares_owned_after_display":"3,483,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-17","scope":"insider"},{"id":3204746,"accession":"0000925421-20-000248","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-20-000248","line_url":"/filing/0000925421-20-000248#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":9.19,"price_display":"9.19","price_state":"stated","total_value":13785.0,"total_display":"13,785.00","total_whole":"13,785","shares_owned_after":3489559.0,"shares_owned_after_display":"3,489,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2020-06-12","scope":"insider"},{"id":3204743,"accession":"0000925421-20-000248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-20-000248","line_url":"/filing/0000925421-20-000248#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7200.0,"shares_display":"7,200","price_per_share":9.21,"price_display":"9.21","price_state":"stated","total_value":66312.0,"total_display":"66,312.00","total_whole":"66,312","shares_owned_after":3491059.0,"shares_owned_after_display":"3,491,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-12","scope":"insider"},{"id":3204740,"accession":"0000925421-20-000248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-20-000248","line_url":"/filing/0000925421-20-000248#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8532.0,"shares_display":"8,532","price_per_share":9.46,"price_display":"9.46","price_state":"stated","total_value":80712.72,"total_display":"80,712.72","total_whole":"80,713","shares_owned_after":3498259.0,"shares_owned_after_display":"3,498,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-12","scope":"insider"},{"id":2067904,"accession":"0000925421-20-000244","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-20-000244","line_url":"/filing/0000925421-20-000244#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":9.38,"price_display":"9.38","price_state":"stated","total_value":65660.0,"total_display":"65,660.00","total_whole":"65,660","shares_owned_after":3506791.0,"shares_owned_after_display":"3,506,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-09","scope":"insider"},{"id":2067902,"accession":"0000925421-20-000244","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-20-000244","line_url":"/filing/0000925421-20-000244#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5659.0,"shares_display":"5,659","price_per_share":9.66,"price_display":"9.66","price_state":"stated","total_value":54665.94,"total_display":"54,665.94","total_whole":"54,666","shares_owned_after":3513791.0,"shares_owned_after_display":"3,513,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-09","scope":"insider"},{"id":2067900,"accession":"0000925421-20-000244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-20-000244","line_url":"/filing/0000925421-20-000244#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8652.0,"shares_display":"8,652","price_per_share":9.66,"price_display":"9.66","price_state":"stated","total_value":83578.32,"total_display":"83,578.32","total_whole":"83,578","shares_owned_after":3519450.0,"shares_owned_after_display":"3,519,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-05","filed_date":"2020-06-09","scope":"insider"},{"id":3240787,"accession":"0000925421-20-000228","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-20-000228","line_url":"/filing/0000925421-20-000228#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4088.0,"shares_display":"4,088","price_per_share":9.55,"price_display":"9.55","price_state":"stated","total_value":39040.4,"total_display":"39,040.40","total_whole":"39,040","shares_owned_after":3528102.0,"shares_owned_after_display":"3,528,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-04","scope":"insider"},{"id":3240784,"accession":"0000925421-20-000228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-20-000228","line_url":"/filing/0000925421-20-000228#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5208.0,"shares_display":"5,208","price_per_share":9.78,"price_display":"9.78","price_state":"stated","total_value":50934.24,"total_display":"50,934.24","total_whole":"50,934","shares_owned_after":3532190.0,"shares_owned_after_display":"3,532,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-04","scope":"insider"},{"id":3240782,"accession":"0000925421-20-000228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-20-000228","line_url":"/filing/0000925421-20-000228#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5669.0,"shares_display":"5,669","price_per_share":9.68,"price_display":"9.68","price_state":"stated","total_value":54875.92,"total_display":"54,875.92","total_whole":"54,876","shares_owned_after":3537398.0,"shares_owned_after_display":"3,537,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-04","scope":"insider"},{"id":7992228,"accession":"0000899243-19-027115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027115","line_url":"/filing/0000899243-19-027115#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Galera Therapeutics, Inc.","issuer_ticker":"GRTX","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":3543067.0,"shares_owned_after_display":"3,543,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-12","filed_date":"2019-11-12","scope":"insider"},{"id":7969872,"accession":"0001104659-19-032920","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-032920","line_url":"/filing/0001104659-19-032920#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":168630.0,"shares_display":"168,630","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":2360820.0,"total_display":"2,360,820.00","total_whole":"2,360,820","shares_owned_after":1769641.0,"shares_owned_after_display":"1,769,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-30","scope":"insider"},{"id":8198987,"accession":"0000925421-19-000179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-19-000179","line_url":"/filing/0000925421-19-000179#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138704.0,"shares_display":"138,704","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":142865.12,"total_display":"142,865.12","total_whole":"142,865","shares_owned_after":4049804.0,"shares_owned_after_display":"4,049,804","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-26","filed_date":"2019-04-29","scope":"insider"},{"id":8198983,"accession":"0000925421-19-000179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-19-000179","line_url":"/filing/0000925421-19-000179#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":563096.0,"shares_display":"563,096","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":579988.88,"total_display":"579,988.88","total_whole":"579,989","shares_owned_after":4188508.0,"shares_owned_after_display":"4,188,508","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-25","filed_date":"2019-04-29","scope":"insider"},{"id":8697297,"accession":"0000925421-19-000157","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-19-000157","line_url":"/filing/0000925421-19-000157#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16403.0,"shares_display":"16,403","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":16895.09,"total_display":"16,895.09","total_whole":"16,895","shares_owned_after":4751604.0,"shares_owned_after_display":"4,751,604","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-24","filed_date":"2019-04-24","scope":"insider"},{"id":8697295,"accession":"0000925421-19-000157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-19-000157","line_url":"/filing/0000925421-19-000157#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27554.0,"shares_display":"27,554","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":28380.62,"total_display":"28,380.62","total_whole":"28,381","shares_owned_after":4768007.0,"shares_owned_after_display":"4,768,007","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-23","filed_date":"2019-04-24","scope":"insider"},{"id":8697291,"accession":"0000925421-19-000157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-19-000157","line_url":"/filing/0000925421-19-000157#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7100.0,"shares_display":"7,100","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":6887.0,"total_display":"6,887.00","total_whole":"6,887","shares_owned_after":4795561.0,"shares_owned_after_display":"4,795,561","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-22","filed_date":"2019-04-24","scope":"insider"},{"id":7858956,"accession":"0000925421-19-000153","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-19-000153","line_url":"/filing/0000925421-19-000153#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28794.0,"shares_display":"28,794","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":28506.06,"total_display":"28,506.06","total_whole":"28,506","shares_owned_after":4802661.0,"shares_owned_after_display":"4,802,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-15","filed_date":"2019-04-15","scope":"insider"},{"id":7858954,"accession":"0000925421-19-000153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-19-000153","line_url":"/filing/0000925421-19-000153#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30908.0,"shares_display":"30,908","price_per_share":1.04,"price_display":"1.04","price_state":"stated","total_value":32144.32,"total_display":"32,144.32","total_whole":"32,144","shares_owned_after":4831455.0,"shares_owned_after_display":"4,831,455","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-12","filed_date":"2019-04-15","scope":"insider"},{"id":7858950,"accession":"0000925421-19-000153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-19-000153","line_url":"/filing/0000925421-19-000153#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57438.0,"shares_display":"57,438","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":62033.04,"total_display":"62,033.04","total_whole":"62,033","shares_owned_after":4862363.0,"shares_owned_after_display":"4,862,363","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-11","filed_date":"2019-04-15","scope":"insider"},{"id":8092327,"accession":"0000925421-19-000149","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-19-000149","line_url":"/filing/0000925421-19-000149#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140230.0,"shares_display":"140,230","price_per_share":1.09,"price_display":"1.09","price_state":"stated","total_value":152850.7,"total_display":"152,850.70","total_whole":"152,851","shares_owned_after":4919801.0,"shares_owned_after_display":"4,919,801","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-10","filed_date":"2019-04-10","scope":"insider"},{"id":8092325,"accession":"0000925421-19-000149","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-19-000149","line_url":"/filing/0000925421-19-000149#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32991.0,"shares_display":"32,991","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":33320.91,"total_display":"33,320.91","total_whole":"33,321","shares_owned_after":5060031.0,"shares_owned_after_display":"5,060,031","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-09","filed_date":"2019-04-10","scope":"insider"},{"id":8092321,"accession":"0000925421-19-000149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-19-000149","line_url":"/filing/0000925421-19-000149#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27525.0,"shares_display":"27,525","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":28075.5,"total_display":"28,075.50","total_whole":"28,076","shares_owned_after":5093022.0,"shares_owned_after_display":"5,093,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-08","filed_date":"2019-04-10","scope":"insider"},{"id":8473584,"accession":"0000925421-19-000145","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-19-000145","line_url":"/filing/0000925421-19-000145#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24661.0,"shares_display":"24,661","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":25154.22,"total_display":"25,154.22","total_whole":"25,154","shares_owned_after":5120547.0,"shares_owned_after_display":"5,120,547","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-05","filed_date":"2019-04-05","scope":"insider"},{"id":8473580,"accession":"0000925421-19-000145","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-19-000145","line_url":"/filing/0000925421-19-000145#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47900.0,"shares_display":"47,900","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":48379.0,"total_display":"48,379.00","total_whole":"48,379","shares_owned_after":5145208.0,"shares_owned_after_display":"5,145,208","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-04","filed_date":"2019-04-05","scope":"insider"},{"id":8473575,"accession":"0000925421-19-000145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-19-000145","line_url":"/filing/0000925421-19-000145#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58033.0,"shares_display":"58,033","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":55711.68,"total_display":"55,711.68","total_whole":"55,712","shares_owned_after":5193108.0,"shares_owned_after_display":"5,193,108","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-03","filed_date":"2019-04-05","scope":"insider"},{"id":7941331,"accession":"0000925421-19-000141","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-19-000141","line_url":"/filing/0000925421-19-000141#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51754.0,"shares_display":"51,754","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":50201.38,"total_display":"50,201.38","total_whole":"50,201","shares_owned_after":5251141.0,"shares_owned_after_display":"5,251,141","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-02","filed_date":"2019-04-02","scope":"insider"},{"id":8414801,"accession":"0000925421-19-000143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-19-000143","line_url":"/filing/0000925421-19-000143#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20610.0,"shares_display":"20,610","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":39159.0,"total_display":"39,159.00","total_whole":"39,159","shares_owned_after":2079394.0,"shares_owned_after_display":"2,079,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-02","scope":"insider"},{"id":7941327,"accession":"0000925421-19-000141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-19-000141","line_url":"/filing/0000925421-19-000141#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116909.0,"shares_display":"116,909","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":111063.55,"total_display":"111,063.55","total_whole":"111,064","shares_owned_after":5302895.0,"shares_owned_after_display":"5,302,895","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-02","scope":"insider"},{"id":8414797,"accession":"0000925421-19-000143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-19-000143","line_url":"/filing/0000925421-19-000143#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106540.0,"shares_display":"106,540","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":197099.0,"total_display":"197,099.00","total_whole":"197,099","shares_owned_after":2100004.0,"shares_owned_after_display":"2,100,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-29","filed_date":"2019-04-02","scope":"insider"},{"id":7941322,"accession":"0000925421-19-000141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-19-000141","line_url":"/filing/0000925421-19-000141#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63100.0,"shares_display":"63,100","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":57421.0,"total_display":"57,421.00","total_whole":"57,421","shares_owned_after":5419804.0,"shares_owned_after_display":"5,419,804","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-29","filed_date":"2019-04-02","scope":"insider"},{"id":8092319,"accession":"0000925421-19-000139","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-19-000139","line_url":"/filing/0000925421-19-000139#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88835.0,"shares_display":"88,835","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":83504.9,"total_display":"83,504.90","total_whole":"83,505","shares_owned_after":5482904.0,"shares_owned_after_display":"5,482,904","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-28","filed_date":"2019-03-28","scope":"insider"},{"id":8092316,"accession":"0000925421-19-000139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-19-000139","line_url":"/filing/0000925421-19-000139#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50749.0,"shares_display":"50,749","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":50241.51,"total_display":"50,241.51","total_whole":"50,242","shares_owned_after":5571739.0,"shares_owned_after_display":"5,571,739","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-27","filed_date":"2019-03-28","scope":"insider"},{"id":8092313,"accession":"0000925421-19-000139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-19-000139","line_url":"/filing/0000925421-19-000139#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177762.0,"shares_display":"177,762","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":179539.62,"total_display":"179,539.62","total_whole":"179,540","shares_owned_after":5622488.0,"shares_owned_after_display":"5,622,488","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-26","filed_date":"2019-03-28","scope":"insider"},{"id":8115409,"accession":"0000925421-19-000114","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000925421-19-000114","line_url":"/filing/0000925421-19-000114#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43800.0,"shares_display":"43,800","price_per_share":1.92,"price_display":"1.92","price_state":"stated","total_value":84096.0,"total_display":"84,096.00","total_whole":"84,096","shares_owned_after":2206544.0,"shares_owned_after_display":"2,206,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-15","filed_date":"2019-03-15","scope":"insider"},{"id":8115408,"accession":"0000925421-19-000114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-19-000114","line_url":"/filing/0000925421-19-000114#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13800.0,"shares_display":"13,800","price_per_share":1.88,"price_display":"1.88","price_state":"stated","total_value":25944.0,"total_display":"25,944.00","total_whole":"25,944","shares_owned_after":2250344.0,"shares_owned_after_display":"2,250,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-14","filed_date":"2019-03-15","scope":"insider"},{"id":8115407,"accession":"0000925421-19-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-19-000114","line_url":"/filing/0000925421-19-000114#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132738.0,"shares_display":"132,738","price_per_share":2.12,"price_display":"2.12","price_state":"stated","total_value":281404.56,"total_display":"281,404.56","total_whole":"281,405","shares_owned_after":2264144.0,"shares_owned_after_display":"2,264,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-13","filed_date":"2019-03-15","scope":"insider"},{"id":6408558,"accession":"0000925421-18-000300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-18-000300","line_url":"/filing/0000925421-18-000300#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20388.0,"shares_display":"20,388","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":46892.4,"total_display":"46,892.40","total_whole":"46,892","shares_owned_after":2396882.0,"shares_owned_after_display":"2,396,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-22","scope":"insider"},{"id":6012679,"accession":"0000925421-18-000298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-18-000298","line_url":"/filing/0000925421-18-000298#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Aerpio Pharmaceuticals, Inc.","issuer_ticker":"ARPO","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":20670.0,"total_display":"20,670.00","total_whole":"20,670","shares_owned_after":5800250.0,"shares_owned_after_display":"5,800,250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-22","scope":"insider"},{"id":6218592,"accession":"0000925421-18-000294","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-18-000294","line_url":"/filing/0000925421-18-000294#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8700.0,"shares_display":"8,700","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":18270.0,"total_display":"18,270.00","total_whole":"18,270","shares_owned_after":2417270.0,"shares_owned_after_display":"2,417,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-17","filed_date":"2018-08-20","scope":"insider"},{"id":6218588,"accession":"0000925421-18-000294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-18-000294","line_url":"/filing/0000925421-18-000294#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Bioventures Ltd; NOVARTIS AG","owner_display_name":"Novartis Bioventures Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8808.0,"shares_display":"8,808","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":18496.8,"total_display":"18,496.80","total_whole":"18,497","shares_owned_after":2425970.0,"shares_owned_after_display":"2,425,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-20","scope":"insider"},{"id":6679518,"accession":"0000925421-18-000292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-18-000292","line_url":"/filing/0000925421-18-000292#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2635.0,"shares_display":"2,635","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":5665.25,"total_display":"5,665.25","total_whole":"5,665","shares_owned_after":2434778.0,"shares_owned_after_display":"2,434,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-16","scope":"insider"},{"id":6679513,"accession":"0000925421-18-000292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-18-000292","line_url":"/filing/0000925421-18-000292#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":7458.0,"total_display":"7,458.00","total_whole":"7,458","shares_owned_after":2437413.0,"shares_owned_after_display":"2,437,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-16","scope":"insider"},{"id":6570242,"accession":"0000925421-18-000290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000925421-18-000290","line_url":"/filing/0000925421-18-000290#line-2","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":2.36,"price_display":"2.36","price_state":"stated","total_value":3776.0,"total_display":"3,776.00","total_whole":"3,776","shares_owned_after":2440713.0,"shares_owned_after_display":"2,440,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-13","filed_date":"2018-08-14","scope":"insider"},{"id":6570238,"accession":"0000925421-18-000290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000925421-18-000290","line_url":"/filing/0000925421-18-000290#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Bioventures Ltd","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5615.0,"shares_display":"5,615","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":13700.6,"total_display":"13,700.60","total_whole":"13,701","shares_owned_after":2442313.0,"shares_owned_after_display":"2,442,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-10","filed_date":"2018-08-14","scope":"insider"}],"collapsed":true,"next_cursor":"2018-08-10|6570238","ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001722271","name":"Akouos, Inc.","url":"/issuer/0001722271","role":"Other","n_filings":1,"first_seen":"2020-07-02","last_seen":"2020-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001563577","name":"Galera Therapeutics, Inc.","url":"/issuer/0001563577","role":"Ten percent owner, Other","n_filings":6,"first_seen":"2019-11-12","last_seen":"2020-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001761612","name":"BICYCLE THERAPEUTICS plc","url":"/issuer/0001761612","role":"Ten percent owner","n_filings":1,"first_seen":"2019-05-30","last_seen":"2019-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001422142","name":"Aerpio Pharmaceuticals, Inc.","url":"/issuer/0001422142","role":"Ten percent owner","n_filings":9,"first_seen":"2017-03-17","last_seen":"2019-04-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001420565","name":"AILERON THERAPEUTICS INC","url":"/issuer/0001420565","role":"Ten percent owner","n_filings":15,"first_seen":"2017-07-05","last_seen":"2019-04-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001636282","name":"Aeglea BioTherapeutics, Inc.","url":"/issuer/0001636282","role":"Ten percent owner","n_filings":4,"first_seen":"2016-04-12","last_seen":"2018-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001481512","name":"Ra Pharmaceuticals, Inc.","url":"/issuer/0001481512","role":"Ten percent owner","n_filings":11,"first_seen":"2016-10-31","last_seen":"2017-06-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001445283","name":"PROTEOSTASIS THERAPEUTICS, INC.","url":"/issuer/0001445283","role":"Ten percent owner","n_filings":1,"first_seen":"2016-02-17","last_seen":"2016-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Tokai Pharmaceuticals Inc","url":"/issuer/0001404281","role":"Ten percent owner","n_filings":7,"first_seen":"2014-09-24","last_seen":"2015-07-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Ten percent owner","n_filings":1,"first_seen":"2014-03-27","last_seen":"2014-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001305253","name":"Celladon Corp","url":"/issuer/0001305253","role":"Ten percent owner","n_filings":1,"first_seen":"2014-02-06","last_seen":"2014-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000737207","name":"Marina Biotech, Inc.","url":"/issuer/0000737207","role":"Ten percent owner","n_filings":4,"first_seen":"2011-01-21","last_seen":"2011-01-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001297709","retrieved_at":"2026-08-22T17:00:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}